Related references
Note: Only part of the references are listed.Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions
Ashwin Dhakal et al.
BRIEFINGS IN BIOINFORMATICS (2022)
Learning meaningful representations of protein sequences
Nicki Skafte Detlefsen et al.
NATURE COMMUNICATIONS (2022)
Blood-brain barrier penetration prediction enhanced by uncertainty estimation
Xiaochu Tong et al.
JOURNAL OF CHEMINFORMATICS (2022)
DeepDTAF: a deep learning method to predict protein-ligand binding affinity
Kaili Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Bioactivity descriptors for uncharacterized chemical compounds
Martino Bertoni et al.
NATURE COMMUNICATIONS (2021)
GraphDTA: predicting drug-target binding affinity with graph neural networks
Thin Nguyen et al.
BIOINFORMATICS (2021)
Rethinking drug design in the artificial intelligence era
Petra Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments
Lifan Chen et al.
BIOINFORMATICS (2020)
DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks
Karim Abbasi et al.
BIOINFORMATICS (2020)
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Miquel Duran-Frigola et al.
NATURE BIOTECHNOLOGY (2020)
Compound-protein interaction prediction with end-to-end learning of neural networks for graphs and sequences
Masashi Tsubaki et al.
BIOINFORMATICS (2019)
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases
Ahmet Sureyya Rifaioglu et al.
BRIEFINGS IN BIOINFORMATICS (2019)
DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks
Mostafa Karimi et al.
BIOINFORMATICS (2019)
Artificial intelligence in drug development: present status and future prospects
Kit-Kay Mak et al.
DRUG DISCOVERY TODAY (2019)
DeepDTA: deep drug-target binding affinity prediction
Hakime Ozturk et al.
BIOINFORMATICS (2018)
SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines
Tong He et al.
JOURNAL OF CHEMINFORMATICS (2017)
Forging the Basis for Developing Protein-Ligand Interaction Scoring Functions
Zhihai Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2017)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
InChI, the IUPAC International Chemical Identifier
Stephen R. Heller et al.
JOURNAL OF CHEMINFORMATICS (2015)
Toward more realistic drug-target interaction predictions
Tapio Pahikkala et al.
BRIEFINGS IN BIOINFORMATICS (2015)
Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis
Jing Tang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
DRUG DISCOVERY Predicting promiscuity
Andrew L. Hopkins
NATURE (2009)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Concordance probability and discriminatory power in proportional hazards regression
M Gönen et al.
BIOMETRIKA (2005)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
